Pediatric Early Development Symposium (PEDS)

The Pediatric Early Development Symposium (PEDS) is dedicated to advancing pediatric cancer drug development through pharmacokinetics, modeling, and improved clinical trial designs.

Key Topics

• How Pharmacokinetics can Enhance the Design of Your Clinical Trial
• Overview of Concepts and Terminology of Pharmacokinetics
• What are critical elements and practical expectations for the FDA
• Dose-Response Relationship: Step from Animals to Humans Fundamentally Flawed?
• How to/Who Identifies the Minimum Number of Patients Needed in a Trial?
• How do you Operationalize a Trial in the Pediatric Population?
• Keynote: Designing Data with a Focus on Pharmacokinetics and Clinical Trials
• How to Bring a Therapeutic Agent to the Clinic for Kids with Cancer Using Data?
• Breakout Sessions – How Can We Break Down Barriers and Better Solve Problems in Clinical Trials?
• Appropriate Use of Extrapolation and Modeling Data from Adults
• AI/ML: The True Future of Drug Development in Pediatric Oncology
• Advanced Modeling Techniques Enhance Future Drug Development
• Future of Clinical Trials in Children with Cancer: We Must Do Better

Who should Attend

Attendees involved or interested in:

• Clinical Operations
• Late Development
• Academic
• Management/Executives
• Patient Advocates
• Key Opinion Leaders
• Medical Affairs
• Regulators
• Project Management
• Clinical Affairs
• Research and Development
• Regulatory Affairs
• Early Development